Contrave Extended-Release 51267-0890
Generic: Naltrexone Hydrochloride And Bupropion Hydrochloride
Product NDC
51267-0890- Manufacturer
- Nalpropion Pharmaceuticals Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 22, 2014
- Listing Expires
- December 31, 2026
- Application
- NDA200063
Need to source Contrave Extended-Release? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bupropion Hydrochloride | 90 mg/1 |
| Naltrexone Hydrochloride | 8 mg/1 |
Drug Class
Aminoketone [EPC]Dopamine Uptake Inhibitors [MoA]Increased Dopamine Activity [PE]
Packaging Options(2)
7 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07)
120 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-99)
External Resources